Morales Castro Rodrigo A, Kern Bianca C, Díaz-Basabe Angélica, Meinen Eveline R, Zhao Danxia, Zhou Yuqing, Castillo Francisca, Monasterio Gustavo, Farcas Vlad, Chávez Myra N, Fransson Jennifer, Villablanca Eduardo J
Division of Immunology and Respiratory Medicine, Department of Medicine Solna (MedS), Karolinska Institute and University Hospital, SE-171 76 Stockholm, Sweden; Center for Molecular Medicine (CMM), Karolinska University Hospital, SE-171 64 Solna, Sweden; Division of Clinical Immunology, Department of Laboratory Medicine (Labmed), Karolinska Institute, SE-141 52 Huddinge, Sweden.
Division of Immunology and Respiratory Medicine, Department of Medicine Solna (MedS), Karolinska Institute and University Hospital, SE-171 76 Stockholm, Sweden; Center for Molecular Medicine (CMM), Karolinska University Hospital, SE-171 64 Solna, Sweden.
Mucosal Immunol. 2025 Aug;18(4):836-847. doi: 10.1016/j.mucimm.2025.04.004. Epub 2025 Apr 17.
Promoting intestinal regeneration and enhancing mucosal healing have emerged as promising therapeutic alternatives for treating intestinal disorders that compromise epithelial barrier integrity and function. However, the cellular and molecular mechanisms underlying these processes remain poorly understood. This knowledge gap is partly due to the lack of reliable and cost-effective in vivo models for studying the mechanisms governing intestinal damage and regeneration. Here, we developed a controlled, inducible, and targeted intestinal epithelial cell (IEC) ablation transgenic zebrafish model that recapitulates features of intestinal damage and regeneration observed in humans. Single-cell RNAseq and live imaging revealed accumulation of macrophages in the recovering intestine, contributing to its regeneration. Furthermore, we observed overexpression of insulin-like growth factor binding protein 1a (igfbp1a) during intestinal damage. Morpholino-mediated knockdown of igfbp1a exacerbated intestinal damage and impaired subsequent regeneration. In summary, we introduced a novel zebrafish model of intestinal damage that enables in vivo high-throughput screening for identifying and validating novel modulators of mucosal healing and intestinal regeneration.
促进肠道再生和增强黏膜愈合已成为治疗损害上皮屏障完整性和功能的肠道疾病的有前景的治疗选择。然而,这些过程背后的细胞和分子机制仍知之甚少。这一知识空白部分归因于缺乏用于研究肠道损伤和再生机制的可靠且经济高效的体内模型。在此,我们开发了一种可控、可诱导且靶向的肠道上皮细胞(IEC)消融转基因斑马鱼模型,该模型概括了在人类中观察到的肠道损伤和再生特征。单细胞RNA测序和活体成像显示巨噬细胞在恢复中的肠道中积累,促进其再生。此外,我们观察到在肠道损伤期间胰岛素样生长因子结合蛋白1a(igfbp1a)的过表达。吗啉代介导的igfbp1a敲低加剧了肠道损伤并损害了随后的再生。总之,我们引入了一种新型的肠道损伤斑马鱼模型,该模型能够进行体内高通量筛选,以鉴定和验证黏膜愈合和肠道再生的新型调节因子。